SCHEMBL127279

SCHEMBL127279

CC(C)(C)c1ccc(Oc2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.77
MAPT P10636 4/20 0.77
ALDH1A1 P00352 4/20 0.77
NPC1 O15118 3/20 0.77
HPGD P15428 3/20 0.77
MAPK1 P28482 2/20 0.77
TSHR P16473 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA9 Q16790 1/20 0.52
KDM4E B2RXH2 3/20 0.52
POLB P06746 1/20 0.52
LMNA P02545 2/20 0.50
TYR P14679 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
FGFR2 P21802 1/20 0.46
GAA P10253 1/20 0.46
TDP1 Q9NUW8 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
APP P05067 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18118972 1.00 RAB9A (0.77) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL427816 1.00 RAB9A (0.77) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL29377311 0.97 RAB9A (0.74) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL12837118 0.92 RAB9A (0.68) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL18934226 0.92 RAB9A (0.68) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL23394825 0.92 RAB9A (0.68) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL17998024 0.92 RAB9A (0.68) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL10000947 0.92 MAPT (0.68) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL799841 0.90 RAB9A (0.65) RAB9AMAPTALDH1A1NPC1HPGD
SCHEMBL19392583 0.90 RAB9A (0.65) RAB9AMAPTALDH1A1NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 639 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368595-A1 NOVEL MOLECULES Xeniopro GmbH (DE) 2025-12-04 US claimed
CN-119683657-A Li (lithium ion battery)3Preparation method of OCl solid electrolyte 溧阳中科海钠科技有限责任公司 2025-03-25 CN claimed
CN-119631213-A Solid electrolyte composition, solid electrolyte membrane comprising same, and all-solid battery 株式会社LG新能源 2025-03-14 CN claimed
CN-119591770-A Organic polymer carrier, Z-N catalyst, and preparation method and application thereof 中国石油天然气股份有限公司 2025-03-11 CN claimed
CN-114031639-A Preparation method of biphosphonate with P-O-C-P structure 烟台大学 2022-02-11 CN claimed
CN-113045934-A Printing ink, application thereof and preparation method of quantum dot film TCL集团股份有限公司 2021-06-29 CN claimed
CN-102575104-B Cross-linkable compositions WACKER CHEMIE AG 2014-05-07 CN claimed
EP-1735259-B1 PENTAERYTHRITOL DERIVATIVES AND A METHOD FOR PREPARATION THEREOF, AND LIQUID CRYSTAL BASE CONTAINING THE SAME AMOREPACIFIC CORP (KR) 2013-07-31 EP claimed
CN-102575104-A Cross-linkable compositions WACKER CHEMIE AG 2012-07-11 CN claimed
EP-1691441-B1 NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING THE SAME UBE INDUSTRIES (JP) 2012-03-07 EP claimed
JP-2011508053-A 2011-03-10 JP claimed
EP-2242776-A1 MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS BASF Corporation (US) 2010-10-27 EP claimed
US-7794885-B2 Non-aqueous electrolytic solution and lithium secondary battery UBE INDUSTRIES, LTD. (JP) 2010-09-14 US claimed
WO-2009088596-A1 MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS BASF CATALYSTS LLC (US) 2009-07-16 WO claimed
CN-100459274-C Nonaqueous electrolyte solution and lithium secondary battery UBE INDUSTRIES (JP) 2009-02-04 CN claimed
US-20070082271-A1 Non-aqueous electrolytic solution and lithium secondary battery UBE INDUSTRIES, LTD. (JP) 2007-04-12 US claimed
CN-1906794-A Nonaqueous electrolyte solution and lithium secondary battery UBE INDUSTRIES (JP) 2007-01-31 CN claimed
EP-1691441-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY Ube Industries, Ltd. (JP) 2006-08-16 EP claimed
US-20250368595-A1 NOVEL MOLECULES Xeniopro GmbH (DE) 2025-12-04 US disclosed
US-3975345-A ELECTROCOATING GENERAL ELECTRIC COMPANY (US) 1976-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368595-A1 NOVEL MOLECULES MUSK, IKZF3, TYR RAB9A 2783/4885MAPT 3885/4885ALDH1A1 950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.